针对AAK1的基于pyrazolo[1,5-a]pyrimidine的宏环激酶抑制剂的开发
Theresa E Mensing1, Christian G Kurz1, Jennifer A Amrhein1
1Institute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany; Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe-University Frankfurt, Max-von-Laue-Str. 15, 60438, Frankfurt am Main, Germany.
新的pyrazolo[1,5-a]pyrimidine宏循环可以选择性地抑制NAK激酶,特别是AAK1,为开发针对动物传播疾病的广泛抗病毒药物提供了有希望的策略.
科学领域:
- 医学化学
- 病毒学
- 分子生物学
背景情况:
- 像SARS-CoV-2这样的动物传染病凸显了新型抗病毒策略的必要性.
- 针对对病毒复制至关重要的宿主蛋白质,如NAK激酶,是一个有前途的方法.
- 现有的NAK激酶抑制剂缺乏选择性,特别是对于AAK1而不是BIKE.
研究的目的:
- 开发具有选择性的NAK激酶抑制剂,特别针对AAK1.
- 识别针对各种RNA病毒的有效抗病毒药物.
主要方法:
- 基于pyrazolo[1,5-a]pyrimidine的宏环NAK抑制剂的结构导向设计.
- 在NAK激酶家族中的结构-活性关系研究.
- 对抑制剂强度,选择性,AP-2复合酸化抑制和抗病毒活性进行评估.
主要成果:
- 在NAK家族中确定具有有前途的强AAK1抑制剂 (化合物16,18和27).
- 由开发的抑制剂表现出强烈的AP-2复合化抑制.
- 对各种RNA病毒的抗病毒活性进行初步评估.
结论:
- 皮拉佐罗[1,5-a]胺宏循环是开发选择性AAK1抑制剂的可行支架.
- 这些选择性抑制剂具有针对宿主-病原体相互作用的广泛抗病毒药物的潜力.
- 需要对其抗病毒功效和作用机制进行进一步的研究.
更多相关视频
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
相关概念视频
Inhibition of Cdk Activity
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
PI3K/mTOR/AKT Signaling Pathway
Anaphase Promoting Complex
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
cAMP-dependent Protein Kinase Pathways
